Development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies.
World's largest financial trading forum for stocks, forex, futures, options & commodities with thousands of professional members. Daily article contributors with actionable trading ideas and educational features aimed at making you a better trader.
Let's share thoughts and charts. Help each other short out the what, when, and why to buy/sell a stock. Share option trade ideas. Disagreement is healthy. Personal attacks are not.
DARA BioSciences, Inc. is a Raleigh, North Carolina based development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. The company continues
... moreto build a diverse pipeline, including candidates for the treatment of metabolic diseases (diabetes), and pain. Presently DARA has two drug candidates with cleared INDâ€™s (Investigational New Drug) Applications from the US FDA. One of these drug candidates KRN5500 has successfully completed a Phase 2a clinical trial treating cancer patients for neuropathic pain. It has a portfolio of drug candidates for neuropathic pain, type 2 diabetes, and psoriasis.less
Safe Harbor Statement
All statements in this news release that are not historical are forward-looking statements within...
ProActive Capital Resources Group
8601 Six Forks Rd., Ste. 160
Raleigh, NC, 27615
United States of America